In a large study of patients with chronic kidney disease, metabolic acidosis independently increased the risk of progressing to end-stage renal disease and death.
Hemodialysis patients who stayed on the phosphate binder sucroferric oxyhydroxide for 2 years had fewer hospitalizations those who switched to another binder for 2 years.
In a small study of hemodialysis patients, the highest 3 quartiles of serum thyrotropin were associated with nearly triple the risks for worse endothelial function.
From 1999 to 2018, the proportion of living kidney donors classified as overweight or mildly obese increased, while the proportion of those considered moderately or morbidly obese has decreased, a study found.